ME
MEDS (MEDS)
$2.25
+9.71%
Mkt Cap —
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$241.50
Range $163.80 – $283.50
Implied Upside
+10633.3%
Consensus $241.50 vs current $2.25
$2.25
+9.71%
Mkt Cap —
No recent rating data.
Price Target (28 analysts)
$241.50
Range $163.80 – $283.50
+10633.3%
Consensus $241.50 vs current $2.25